A Science and Technology Blog
Information shared by the three stakeholders — NEJM, NIAID and Gilead — on critical issues about whether the drug’s ability to reduce mortality is statistically significant and which category of…
Contrary to claims made in NEJM, the Chinese woman did not transmit the novel coronavirus to the German during the incubation period. She had symptoms during her stay in Germany…
Indian doctors at the Government Medical College and Hospital, Chandigarh have their ‘Image in Clinical Medicine’ photo published in the New England Journal of Medicine (NEJM) retracted. It is not…
Lower nicotine content in cigarettes is an idea whose time has come. On July 28, 2017, the U.S. Food and Drug Administration struck panic among tobacco companies by announcing a…
There is no significant difference in the disability outcomes for patients who have suffered acute stroke, whether they received treatment lying flat on the back with the face upwards or…
The emergence of resistance to the artemisinin drug, a potent anti-malarial medicine, now threatens to affect the big gains achieved in recent years in reducing the global burden of malaria…
On June 21, the National Institutes of Health gave permission for starting the first ever clinical trial using CRISPR genome-editing technology, Nature news notes. The trial, which will begin before…
More than 50 years after the infectious pathogen, rubella virus, was identified as the cause of an epidemic of congenital defects, the Centres for Disease Control and Prevention (CDC) in…
